Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for pediatric chemotherapy-induced nausea and vomiting
IRCT20120415009475N14Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Olanzapine with Placebo (2 arms). Primary endpoints: Occurrence of nausea, Occurrence of vomiting and 2 more. Started Nov 2023; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on IRCT20120415009475N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120415009475N14.